newsroom
$HIMS · BREAKING: Hims & Hers Earnings Breakdown | The Growth Nobody's Talking About
now playing · $HIMS
$HIMS···bullish· high· postravis hoium
Hollyman: Hims & Hers Q1 shows inflection despite 4% growth; raised guidance signals 30%+ growth ahead
Q1 was the last quarter of legal GLP-1 compounding creating a tough comp; new Novo Nordisk branded GLP-1s and peptide pipeline should drive 25-30% growth in 2026 with long-term pl…